Silverback Therapeutics Competitors and Similar CompaniesClear all

NovoCure's competitors and similar companies include Zymeworks.
NovoCure
NovoCure
NovoCure is a company engaged in the development, manufacture, and commercialization of solutions for the treatment of solid tumors.
Zymeworks
Zymeworks
Zymeworks is a computational biotechnology company focused on optimizing therapeutic antibodies and other protein-based therapeutics.
Founding Date
Founding Date
2000
Founding Date
2003
Type
Type
Public
Type
Public
Tags
Locations
Locations
Saint Helier, JE HQ
München, DE
Haifa, IL
Tokyo, JP
Root, CH
Malvern, US
New York, US
see more
Locations
Vancouver, CA HQ
Seattle, US
Employees
Employees
1,488
Employees
45519% increase
Valuation ($)
Valuation ($)
1.8 b
Valuation ($)
973.3 m

Financial

Revenue (est.)
Revenue (est.)
$655.4m (FY, 2025)
Revenue (est.)
$106m (FY, 2025)
Net income
Net income
($136.2m) (FY, 2025)
Net income
($81.1m) (FY, 2025)
For sources of this data, please see the company profile

View Company Profiles

Zymeworks
HQ
Vancouver, CA
Employees
455↑ 19% increase

Zymeworks is a computational biotechnology company focused on optimizing therapeutic antibodies and other protein-based therapeutics.

View company